These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies. Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366 [TBL] [Abstract][Full Text] [Related]
3. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
4. Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study. Plowey ED; Ziskin JL Acta Neuropathol Commun; 2016 Oct; 4(1):114. PubMed ID: 27793193 [TBL] [Abstract][Full Text] [Related]
5. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
6. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review. Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963 [TBL] [Abstract][Full Text] [Related]
7. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease. Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355 [TBL] [Abstract][Full Text] [Related]
8. Spatial proteomics reveals human microglial states shaped by anatomy and neuropathology. Mrdjen D; Amouzgar M; Cannon B; Liu C; Spence A; McCaffrey E; Bharadwaj A; Tebaykin D; Bukhari S; Hartmann FJ; Kagel A; Vijayaragavan K; Oliveria JP; Yakabi K; Serrano GE; Corrada MM; Kawas CH; Camacho C; Bosse M; Tibshirani R; Beach TG; Angelo M; Montine T; Bendall SC Res Sq; 2023 Jun; ():. PubMed ID: 37398389 [TBL] [Abstract][Full Text] [Related]
9. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086 [TBL] [Abstract][Full Text] [Related]
11. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease. Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390 [TBL] [Abstract][Full Text] [Related]
13. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Streit WJ; Braak H; Xue QS; Bechmann I Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731 [TBL] [Abstract][Full Text] [Related]
14. Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease. Taddei RN; Perbet R; Mate de Gerando A; Wiedmer AE; Sanchez-Mico M; Connors Stewart T; Gaona A; Melloni A; Amaral AC; Duff K; Frosch MP; Gómez-Isla T JAMA Neurol; 2023 Nov; 80(11):1209-1221. PubMed ID: 37812432 [TBL] [Abstract][Full Text] [Related]
15. AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy. Borreca A; Latina V; Corsetti V; Middei S; Piccinin S; Della Valle F; Bussani R; Ammassari-Teule M; Nisticò R; Calissano P; Amadoro G Mol Neurobiol; 2018 Oct; 55(10):8124-8153. PubMed ID: 29508283 [TBL] [Abstract][Full Text] [Related]
16. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Lace G; Savva GM; Forster G; de Silva R; Brayne C; Matthews FE; Barclay JJ; Dakin L; Ince PG; Wharton SB; Brain; 2009 May; 132(Pt 5):1324-34. PubMed ID: 19321462 [TBL] [Abstract][Full Text] [Related]
17. Application of deep learning to understand resilience to Alzheimer's disease pathology. Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663 [TBL] [Abstract][Full Text] [Related]
18. A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients. Furcila D; DeFelipe J; Alonso-Nanclares L J Alzheimers Dis; 2018; 64(2):417-435. PubMed ID: 29914033 [TBL] [Abstract][Full Text] [Related]
19. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers. Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603 [TBL] [Abstract][Full Text] [Related]
20. Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology. Dávila-Bouziguet E; Casòliba-Melich A; Targa-Fabra G; Galera-López L; Ozaita A; Maldonado R; Ávila J; Delgado-García JM; Gruart A; Soriano E; Pascual M Brain; 2022 Apr; 145(2):729-743. PubMed ID: 34424282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]